AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in ...

Palantir stock continues to crush the broader market, but can the company sustain these gains over the next several months?

Palantir's massive run-up is tied to its valuation increasing. Any stock in the market could double under the same ...

Two companies have recently seen their stock prices head higher on optimism about the future growth in AI spending. Palantir ...

Investors are hopeful that C3.ai (NYSE: AI) can deliver results similar to Palantir (NASDAQ: PLTR). *Stock prices used were the afternoon prices of July 23, 2025. The video was published on July 25, ...

Lance Roberts is a seasoned financial strategist and economist with more than 30 years of experience in investment management, private banking and venture capital. He currently serves as chief ...

The data mining and artificial intelligence (AI) specialist is firing on all cylinders, but the answer is still complicated.

Airbnb is a cash-flow machine and a great stock to own.